Sánchez-Valle, R., Heslegrave, A., Foiani, M. S., Bosch, B., Antonell, A., Balasa, M., . . . Fox, N. C. (2018). Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease. Alzheimer's research & therapy, 10(1), 113-6. https://doi.org/10.1186/s13195-018-0439-y
Chicago Style (17th ed.) CitationSánchez-Valle, Raquel, Amanda Heslegrave, Martha S. Foiani, Beatriz Bosch, Anna Antonell, Mircea Balasa, Albert Lladó, Henrik Zetterberg, and Nick C. Fox. "Serum Neurofilament Light Levels Correlate with Severity Measures and Neurodegeneration Markers in Autosomal Dominant Alzheimer’s Disease." Alzheimer's Research & Therapy 10, no. 1 (2018): 113-6. https://doi.org/10.1186/s13195-018-0439-y.
MLA (9th ed.) CitationSánchez-Valle, Raquel, et al. "Serum Neurofilament Light Levels Correlate with Severity Measures and Neurodegeneration Markers in Autosomal Dominant Alzheimer’s Disease." Alzheimer's Research & Therapy, vol. 10, no. 1, 2018, pp. 113-6, https://doi.org/10.1186/s13195-018-0439-y.